About the Journal

About

Cancer Biome and Targeted Therapy (CBTT) publishes peer-reviewed, interdisciplinary research focused on the tumor microenvironment, microbial influences, immune dynamics, and mechanisms of resistance to cancer therapies.

Aims and Scope

Cancer Biome and Targeted Therapy (CBTT) is a peer-reviewed, open-access journal publishing high-quality, interdisciplinary research at the intersection of tumor biology, immunology, microbiology, and precision oncology. The journal advances understanding of the cancer biome, the complex biological and microbial ecosystem surrounding tumor cells, and its impact on cancer progression, immune modulation, therapeutic resistance, and clinical outcomes.

CBTT welcomes original research, reviews, and translational studies addressing key areas, including:

  • Immunology: Immune tumor microenvironment and host–tumor interactions.
  • Microbiology: Microbial ecosystems including bacterial, fungal, viral, and parasitic components, and their influence on the tumor niche.
  • Biochemistry & Molecular Biology: Molecular cancer mechanisms, signaling, biomarkers, diagnostics, and therapeutic targets.
  • Pharmacology and therapeutics: Resistance mechanisms and the development of precision and targeted therapies.
  • Molecular Medicine: Molecular and genetic mechanisms underlying cancer initiation, progression, and therapy response.

The journal supports research bridging basic science and clinical application to foster innovation in cancer diagnostics, prognostics, and treatment. View our Editorial Team

CBTT upholds the highest standards of ethical open-access publishing, adhering to DOAJ and COPE guidelines while maintaining full editorial independence. Articles are assigned DOIs, and authors are encouraged to use ORCID for persistent researcher identification. Metadata is regularly updated to enhance discoverability and indexing.

Mission Statement

Cancer Biome and Targeted Therapy (CBTT) is committed to advancing a systems-level understanding of cancer by exploring the biological, immunological, microbial, and therapeutic dimensions of the tumor environment. Our mission is to provide an open-access platform for high-quality, peer-reviewed research that uncovers how the complex interplay between tumors and their surrounding ecosystems influences disease behavior, therapeutic resistance, and clinical outcomes.

By integrating insights from immunology, microbiology, pharmacology, and computational biology, CBTT aims to catalyze innovation in cancer prevention, diagnosis, and precision treatment. We are dedicated to supporting interdisciplinary collaboration, global scientific exchange, and the responsible dissemination of knowledge that ultimately improves patient care.

Open access

Under the open access model, Cancer Biome and Targeted Therapy (CBTT) does not apply embargoes or subscription restrictions. All articles are made freely accessible immediately upon publication, allowing readers instant and unrestricted access to the content. All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). https://creativecommons.org/licenses/by/4.0/.

As the authors of articles published in Cancer Biome and Targeted Therapy, you retain the copyright to your work. By publishing with us, you allow any third party the right to use, reproduce, and distribute your article in perpetuity, given that the terms of the applicable open-access license are followed.

Open Journal System and Archival System

Cancer Biome and Targeted Therapies is hosted on the Open Journal Systems (OJS) platform, developed and maintained by the Public Knowledge Project (PKP) with daily backups, digital preservation, and archiving on the PKP Preservation Network using the LOCKSS Program. While the journal utilizes this platform to manage editorial workflows and online publishing, the journal and its publisher assume no liability for any technical issues, data loss, service interruptions, or privacy breaches that may arise from using the OJS platform.

Although the platform complies with relevant privacy and data protection regulations, including the British Columbia Freedom of Information and Protection of Privacy Act (FIPPA) and the European Union’s General Data Protection Regulation (GDPR), the journal does not control or guarantee the performance, availability, or security of the platform’s infrastructure. Using this website, users acknowledge and agree that the journal and its publisher shall not be held responsible for any damages or losses resulting from platform-related failures or external data handling processes managed by PKP or its hosting providers.

Publishing frequency

Cancer Biome and Targeted Therapy (CBTT) is an international, peer-reviewed, open-access scientific journal. The journal currently follows a quarterly publication schedule, releasing three issues per year in February, May, August, and November. Upon reaching a sustained volume of unsolicited submissions and achieving indexation milestones, the journal will transition to a continuous publishing model.

The Cancer Biome and Targeted Therapy journal does not apply embargoes or subscription restrictions. All articles are freely available immediately upon publication. While manuscripts are reviewed and accepted on a rolling basis, final publication typically coincides with the release of the next scheduled issue. As a result, accepted articles may be subject to a short waiting period before formal publication, depending on the issue calendar. Authors will be notified of the expected publication date upon acceptance. We appreciate your understanding as we maintain a consistent and high-quality publication schedule.

Language

English

Article processing charge (APC)

Cancer Biome and Targeted Therapy (CBTT) does not charge any publication fees, and all articles are freely accessible to readers.

Self-Archiving Policy (For Accepted Manuscripts):

Authors are permitted and encouraged to post the accepted version (postprint) of their manuscript, after peer review but before final typesetting, in personal repositories, institutional archives, or recognized preprint servers.

To preserve the integrity of the published record, authors should:

  • Clearly label the version as "Accepted Manuscript."
  • Include the DOI and citation to the final published version once available
  • Do not share the formatted publisher PDF without prior permission

This policy supports author visibility, compliance with funder requirements, and the broader goals of open science.

Publisher Statement and Contact

Publisher: © GCINC Press (Imprint of Global Consulting Inc.). GCINC Press is the publishing division of Global Consulting Inc., the legal entity responsible for the journal’s management and operations.

Publisher Address: Global Consulting Inc (GCINC Press), 522 W Riverside Ave Ste N., Spokane, WA 99201, USA. Email: submissions@cancerbiometherapy.com

Last updated: October 2025